Search by Drug Name or NDC

    NDC 55150-0351-01 Icatibant 30 mg/3mL Details

    Icatibant 30 mg/3mL

    Icatibant is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is ICATIBANT ACETATE.

    Product Information

    NDC 55150-0351
    Product ID 55150-351_56d5047e-3f99-4100-af4f-388870986ced
    Associated GPIs
    GCN Sequence Number 064564
    GCN Sequence Number Description icatibant acetate SYRINGE 30 MG/3 ML SUBCUT
    HIC3 A7M
    HIC3 Description BRADYKININ B2 RECEPTOR ANTAGONISTS
    GCN 14778
    HICL Sequence Number 035962
    HICL Sequence Number Description ICATIBANT ACETATE
    Brand/Generic Generic
    Proprietary Name Icatibant
    Proprietary Name Suffix n/a
    Non-Proprietary Name Icatibant
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 30
    Active Ingredient Units mg/3mL
    Substance Name ICATIBANT ACETATE
    Labeler Name Eugia US LLC
    Pharmaceutical Class Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213521
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0351-01 (55150035101)

    NDC Package Code 55150-351-01
    Billing NDC 55150035101
    Package 1 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-08-14
    NDC Exclude Flag N
    Pricing Information N/A